Collaborating on Cancer Care
The major challenge in diagnosing the potential for breast cancer at the premalignant stages lies in recognizing it.
Michael Misialek |
Commenting in response to the JAMA article published in March 2015 on diagnostic concordance among pathologists interpreting breast biopsy specimens (1)…
The major challenge in diagnosing the potential for breast cancer at the premalignant stages lies in recognizing it. In many cases, needle biopsy does a good initial job by allowing the pathologist to properly triage the patient and identify a lesion that’s better examined with an excisional biopsy. Practices that don’t do secondary prospective review of problematic cases face an additional obstacle to diagnosis; this is critical for high quality work and I would personally consider it mandatory. A robust quality management program that includes specific criteria for mandatory prospective review of complex cases – things that will result in significant clinical impact – is imperative to render quality, reproducible diagnoses. One final challenge that may exist for some practices is the lack of a “team effort” by collaborating clinicians. It’s imperative for pathologists to have access to other treating clinicians like radiologists, oncologists, and surgeons. No field of medicine can practice in isolation.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.